| Batch Notification Number |
BN-OL-2022-10-06-5215
|
| FDA Registered Product/Generic Name |
Polymyxin B (as Sulfate) + Neomycin (as Sulfate) + Dexamethasone
|
| Brand Name |
-
|
| Dosage Strength |
8,000 units/ 3.5 mg/ 1 mg/ mL
|
| Dosage Form |
Suspension Otic (Sterile)
|
| Registration Number |
DR-XY28136
|
| Batch Number |
N/A
|
| Lot Number |
230904
|
| Product Expiration Date |
03/2024
|
| Issuance Date |
7 October 2022
|